Retatrutides safety profile is consistent with whats already been observed GLP-1 receptor agonists and combined GLP-1/GIP receptor agonists, meaning the expected side effects are primarily gastrointestinal (GI) in nature: Nausea, vomiting, diarrhea, and constipation
After having her IUD removed in May 2024, Hatcher had a period that lasted 45 days, and started experiencing symptoms of PCOS, such as fatigue and irregular menstrual cycles
The Complete Guide to the LifeVantage MIND-BODY GLP-1 System Colin Raymond Oct 15, 2025 4 min read Updated: May 19 More Than Weight Loss Its Whole-Body Wellness, Cellular Balance, and Sustainable Vitality In the world of wellness, a few breakthroughs redefine how we think about health
As the trials progress, CagriSema could become a key player in the field of obesity treatment, offering a potent option for individuals struggling to lose weight
However, OrderlyMeds advises that the medication may not be suitable for all and that pricing remains complex due to brand variations and insurance coverage